In a pooled analysis, the high-dose inactivated influenza vaccine provided superior protection compared with the standard-dose vaccine against hospitalisations for influenza or pneumonia; it also ...

The Food and Drug Administration reversed course and agreed to begin a review of Moderna’s application to sell a new seasonal flu shot after the vaccine maker agreed to conduct additional testing in ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu ...

The Food and Drug Administration has reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, company and federal officials said ...